Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK/MAPK and JNK/MAPK pathways regulation

Kidney and Blood Pressure Research

Volumn 37, Issue 6, 2013, Pages 631-640

  Gao, Xiang ^a   Wu, Guiqun ^a   Gu, Xiangchen ^a   Fu, Lili ^a   Mei, Changlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Kruppel like factor 15; Mitogen activated protein kinase; Renal interstitial fibrosis; Transforming growth factor 1

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 15; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; IMMUNOFLUORESCENCE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL MODEL; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; FIBROSING ALVEOLITIS; IN VITRO STUDY; NEPHRECTOMY; RENAL INTERSTITIAL FIBROSIS; UPREGULATION;

ANIMALS; CELLS, CULTURED; FIBROSIS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY DISEASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84891079067     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355743     Document Type: Article

References (22)

1. Eddy AA, Neilson EG: Chronic kidney disease progression. J Am Soc Nephrol 2006;17:2964-2966.
2. Wang S, Wilkes MC, Leof EB, Hirschberg R: Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. Faseb J 2005;19:1-11.
3. Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND: Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 2009;297:F106-113.
4. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ: Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 2001;59:1626-1640.
5. Bottinger EP: TGF-beta in renal injury and disease. Semin Nephrol 2007;27:309-320.
6. Wang W, Koka V, Lan HY: Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005;10:48-56.
7. Watanabe H, de Caestecker MP, Yamada Y: Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 2001;276:14466-14473.
8. Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. Embo J 1999;18:1345-1356.
9. Chin BY, Mohsenin A, Li SX, Choi AM, Choi ME: Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol 2001;280:F495-504.
10. Dang DT, Pevsner J, Yang VW: The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 2000;32:1103-1121.
11. Uchida S, Tanaka Y, Ito H, Saitoh-Ohara F, Inazawa J, Yokoyama KK, Sasaki S, Marumo F: Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor. Mol Cell Biol 2000;20:7319-7331.
12. Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, Nakamura K, Nakamura T, Yamauchi T, Kubota N, Kadowaki T, Matsuki Y, Ogawa W, Hiramatsu R, Kasuga M: Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005;280:12867-12875.
13. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar A, Lin Z, Sen-Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Liao R, Jain MK: Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2007;104:7074-7079.
14. Leenders JJ, Wijnen WJ, Hiller M, van der Made I, Lentink V, van Leeuwen RE, Herias V, Pokharel S, Heymans S, de Windt LJ, Hoydal MA, Pinto YM, Creemers EE: Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity. J Biol Chem 2010;285:27449-27456.
15. Gray S, Wang B, Orihuela Y, Hong EG, Fisch S, Haldar S, Cline GW, Kim JK, Peroni OD, Kahn BB, Jain MK: Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab 2007;5:305-312.
16. Haldar SM, Lu Y, Jeyaraj D, Kawanami D, Cui Y, Eapen SJ, Hao C, Li Y, Doughman YQ, Watanabe M, Shimizu K, Kuivaniemi H, Sadoshima J, Margulies KB, Cappola TP, Jain MK: KLF15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med 2010;2:26ra26.
17. Gao X, Huang L, Grosjean F, Esposito V, Wu J, Fu L, Hu H, Tan J, He C, Gray S, Jain MK, Zheng F, Mei C: Lowprotein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney Int 2011;79:987-996.
18. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998;9:224-230.
19. Taal MW, Chertow GM, Rennke HG, Gurnani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM, Mackenzie HS: Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 2001;280:F343-355.
20. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002;16:1466-1471.
21. Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, Gray S, Leask A, Jain MK: The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol 2008;45:193-197.
22. Liang Q, Molkentin JD: Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 2003;35:1385-1394.